Top in rheumatology: Combatting TikTok misinformation; PFAPA syndrome triggers
Rheumatologist Micah Yu, MD, has been combatting medical misinformation by bringing awareness to nearly 80,000 people on TikTok.
In a Healio exclusive interview, Yu discussed his social media efforts and what technology means for the future of medicine. It was the top story in rheumatology last week.
Another top story covered a study that found emotional distress may trigger flares of periodic fever, aphthous stomatitis, pharyngitis and adenitis.
Read these and more top stories in rheumatology below:
‘We need to adapt’: Rheumatologist on TikTok battles misinformation for 78K followers
In a specialty like rheumatology, patient education can be an important factor in disease management, whether it’s combatting misinformation, improving treatment compliance or helping patients better advocate for themselves. Read more.
Emotional distress may trigger PFAPA flares
Emotional distress may trigger flares of periodic fever, aphthous stomatitis, pharyngitis and adenitis, or PFAPA syndrome, according to data published in Pediatric Rheumatology. Read more.
Humira biosimilar approval paused after FDA finds ‘deficiencies’ at manufacturing facility
The FDA approval of Alvotech’s Humira biosimilar is on hold until the company can address “certain deficiencies” the administration found during an inspection of a manufacturing facility, according to a press release. Read more.
Litifilimab superior to placebo in reducing tender swollen joints in lupus
Litifilimab (BIIB059, Biogen) was superior to placebo in reducing tender and swollen joints among patients with systemic lupus erythematosus, according to phase 2 trial data published in the New England Journal of Medicine. Read more.
COVID-19 vaccine booster dose effective at preventing infection in patients with lupus
Patients with systemic lupus erythematous achieved an improved serological response following a booster COVID-19 vaccine dose, according to data collected during the omicron BA.1 wave in New York and published in The Lancet Rheumatology. Read more.